A novel integrated and immunological strategy for the therapy of chronic hepatitis B

Tipologia
Progetti finalizzati
Programma di ricerca
Progetti ordinari di Ricerca Finalizzata
Coordinatore
Ottonello Simone

Aree / Gruppi di ricerca

Partecipanti al progetto

Descrizione del progetto

Virus-specific T cell dysfunction is an important determinant of virus persistence in HBV infection and chronic exposure to high antigen loads is likely involved in altering the function of costimulatory pathways and regulatory T cell subsets/cytokines. We have performed the first transcriptome analysis of HBV-specific and total CD8 T cells from chronic HBV patients and identified specific dysregulated genes and cellular functions that represent potential targets for functional T cell restoration strategies. The main goals of this project are to functionally validate genes and pathways revealed by gene expression profiling and to extend this analysis to chronic patients under nucleos(t)ide analogues (NUC) therapy. This will allow to gain the information that is necessary to design novel combination therapies for naïve and NUC treated patients through the targeted manipulation of complementary regulatory pathways.

Risultati e pubblicazioni

Fisicaro, Paola, Barili, Valeria, Montanini, Barbara, Acerbi, Greta, Ferracin, Manuela, Guerrieri, Francesca, Salerno, Debora, Boni, Carolina, Massari, Marco, Cavallo, M Cristina, Grossi, Glenda, Giuberti, Tiziana, Lampertico, Pietro, Missale, Gabriele, Levrero, Massimo, Ottonello, Simone, Ferrari, Carlo (2017)
Targeting mitochondrial dysfunction can restore antiviral activity of exhausted HBV-specific CD8 T cells in chronic hepatitis B.
https://air.unipr.it/handle/11381/2822739

Campusnet SCVSA   |   Versione Mobile
Location: https://scvsa-servizi.campusnet.unipr.it/robots.html
Non cliccare qui!